30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

NuVasive Launches AttraX Scaffold Biologic in the US -

NuVasive commenced U.S. launch of AttraX® Scaffold absorbent ceramic-collagen bone graft. The surface of AttraX has been validated in preclinical testing to drive increased bone formation and faster fusion vs. traditional ceramic bone grafts, reportedly supporting differentiation of mesenchymal stem cells into bone-forming osteoblasts without the addition of growth factors. (NuVasive, Inc., 6/12/18)